NCT05903924View on ClinicalTrials.gov

Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

PHASE3CompletedINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

September 9, 2023

Primary Completion Date

April 6, 2024

Study Completion Date

April 24, 2024

Conditions
Motion Sickness
Interventions
DRUG

Tradipitant

Oral Capsule

DRUG

Placebo

Oral Capsule

Trial Locations (5)

10016

Manhattan Medical Research, New York

90404

Santa Monica Clinical Trials, Santa Monica

94607

Pacific Research Partners, San Diego

95124

Lumos Clinical Research, San Jose

02169

Beacon Clinical Research, Boston

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY